Urit Group

I. Company Profile Urit Group is a first-class manufacturer, supplier and service provider of medical diagnostic products in China, a national high-tech enterprise, a project unit of the "Major Special Project for High-Performance Medical Diagnostic Equipment", and has the "National and Local Joint Engineering Laboratory for Immunodiagnostic Reagents" accredited by the National Development and Reform Commission. Based on clinical needs, after years of continuous development, relying on a strong R&D team and capital investment, and integrating independent innovative technologies, Urit has successfully launched nine major product series including urine analysis, blood cell analysis, and biochemical analysis, with more than 240 patents accumulated, participated in the preparation and verification of 31 national pharmaceutical industry standards, and passed ISO9001, ISO13485 international quality system certification and EU CE product certification, and is currently one of the domestic IVD enterprises with the most types of testing products. Adhering to the global development strategy, Urit has now grown into a large health-care medical technology group integrating R&D, production, sales, and service, established a complete and leading domestic and overseas marketing service system, and its full range of products and solutions are sold to more than 180 countries and regions worldwide, serving more than 200,000 medical institutions. Urine analyzers have become excellent domestic products in the field of in-vitro diagnostics with a market share exceeding imported brands. II. Pioneer, leader, and innovator in China's urine testing field Vice President Unit of the In-Vitro Diagnostics Industry Branch of the National Health Industry Enterprise Management Association (CAIVD) Member Unit of the National Technical Committee for Standardization of Clinical Laboratory and In-Vitro Diagnostic Systems Member of the Standing Council of the In-Vitro Diagnostics (IVD) Branch of the China Medical Device Industry Association Council Member of the Board of Directors of the China Medical Equipment Association Vice President Unit of the Laboratory Medicine Branch of the Bethune Spirit Research Association President Unit of the Guangxi Medical Device Industry Association III. Corporate History In 1984, China's first urine analyzer was born at Urit, announcing the transition of domestic urine testing from manual to automated era. In 1999, the first batch of successfully developed blood cell analyzers were launched, opening a new pattern of diversified development of testing products for Urit. In 2005, the fully automatic biochemical analyzer was successfully introduced to the market. In 2009, the National Development and Reform Commission accredited the "National and Local Joint Engineering Laboratory for Immunodiagnostic Reagents". In 2011, China's first five-class blood cell analyzer with four-angle laser scattering was successfully launched, breaking the monopoly of imported brands on blood cell analyzers. In 2015, urine, blood cell, and biochemical instruments were selected into the directory of excellent domestic medical equipment. In 2016, the URIT-30 portable urine analyzer was launched into space with Tiangong-2, becoming one of the first instruments used for astronaut physical testing and extreme environment scientific experiments. In 2017, a constant-speed full-automatic biochemical analyzer with a speed of 800T/H was launched. In 2018, the world's first AI-based US-2000 series artificial intelligence modular urine analysis solution was launched. In 2020, the world's first full-chain urine analysis line of the Great Wall series US-3000, achieving intelligent detection of urine dry chemistry, urine sediment, and urine specific proteins, made a brilliant debut. In 2021, the URIT portable urine analyzer went to space again, becoming the first domestic urine machine to enter the Tianhe core module. In 2022, the 6-series full-automatic blood analyzer using nucleic acid fluorescence staining technology was launched. In 2023, URIT urine analysis products set sail again on Tianzhou-6; in 2023, the Kunlun series BS-7000 blood analysis line was launched; in 2023, the IA-260 full-automatic chemiluminescence immunoassay analyzer was launched. In 2024, the CNAS-accredited Urit Testing Center was officially put into use. IV. Benefits 1. Comprehensive compensation system, training system, and statutory five insurances and one housing fund. 2. Special bonuses: innovation award, performance award, newcomer progress award, excellent team award, excellent manager award, etc. 3. Free working meals and annual physical examination. 4. Regularly organized basketball, badminton, football, balloon volleyball, outdoor expansion, and other activities.